Denali Therapeutics logo

Associate Director, Access Strategy and Reimbursement (Remote - East Coast Based)

Denali Therapeutics

Any City, USRemotePosted 2 days ago
Full TimeDirector & AboveCommercial & Pharma SalesBiotechnology
Original posting ↗

Summary

The Associate Director, Access Strategy and Reimbursement will serve as the national expert to address systemic and account-level access barriers and to facilitate preventing and solving the most complex patient access issues to ensure smooth fulfillment, on-boarding and adherence. This is a critical role for ensuring a seamless patient experience and will balance the needs for strategy, tactical operations and customer engagement. As part of an emerging biopharma company, the ideal candidate will thrive in a resource efficient environment, demonstrate a clear passion for patient-focused execution and excel at collaborating and influencing across customer-engagement roles. This role is remote and the candidate should be based on the East Coast.

Job description

Key Accountabilities/Core Job Responsibilities

National Access Strategy and Reimbursement

  • Provides expertise on coverage and reimbursement to ensure seamless access via effective strategies and efficient processes, working directly with key stakeholders across the patient access journey.
  • Lead the development, maintenance and delivery of training for resources and tools that empower account and patient support teams to navigate evolving access & reimbursement dynamics (i.e. reimbursement processes, claims submissions, procedures and coding requirements of payer organizations including commercial, local, government, etc.)
  • Analyze trends and barriers and develop strategies to anticipate and prevent patient access issues; translate strategies into actionable plans.
  • Responsible for the account access and reimbursement dashboard to support the reporting and analysis of key measures.
  • Remain current on key managed care, reimbursement and policy activities and the implications for patient access. Communicate policy updates and payer trends related to approved products to key stakeholders.
  • Partner effectively with members of the account team, serving as the reimbursement expert to provide support to healthcare providers for escalated patient-level access issues.
  • Maintain a deep understanding of Hunter syndrome and MPS therapy area, customer needs and market access dynamics.

Cross-Functional Collaboration

  • Foster collaborative relationships with field-based and home-office teams to ensure a unified approach to supporting patients/caregivers and healthcare providers.
  • Promote a culture of continuous improvement through regular feedback and process enhancements based on patient/caregiver, healthcare provider and payer insights.
  • Lead cross-functional teams and partner with key stakeholders on strategic patient access, coverage and reimbursement initiatives and projects.

Requirements

  • Bachelor's degree, life sciences preferred
  • Minimum of 8+ years of experience in pharma/healthcare
  • At least 2+ years of patient access strategy experience
  • At least 2+ years of field reimbursement experience
  • Preferred experience in rare disease, pediatrics and complex therapies
  • Ability to effectively engage with customers and be a creative problem solver
  • Proven expertise and experience with market access across payer types, healthcare policy and navigating the access, coverage and reimbursement environment
  • Demonstrated success working in a complex matrix working independently and cooperatively within teams
  • Strong strategic, analytical, collaborative skills
  • Ability to travel as required

Company overview

Denali Therapeutics is a pioneering biotechnology company focused on developing innovative therapeutics for neurodegenerative and lysosomal storage diseases. Founded in 2015 and headquartered in South San Francisco, California, the company has developed a proprietary TransportVehicle™ (TV) platform designed to enable biotherapeutics to cross the blood-brain barrier, addressing one of the most significant challenges in treating central nervous system disorders. Denali's pipeline includes promising candidates for conditions such as Hunter syndrome (MPS II), Parkinson's disease, frontotemporal dementia, Sanfilippo syndrome (MPS IIIA), and MPS I, with several programs in advanced clinical development stages. The company collaborates with major pharmaceutical partners including Biogen and Sanofi, leveraging its platform technology to create a new class of barrier-crossing therapeutics. With approximately 500-1,000 employees and operations spanning multiple locations including Salt Lake City, Denali Therapeutics represents a leading force in neuroscience drug development, combining deep scientific expertise with a patient-centric approach to transform treatment paradigms for serious neurological conditions.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.